{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:23:45Z","timestamp":1761812625093,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["World Neurosurgery"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.wneu.2018.06.150","type":"journal-article","created":{"date-parts":[[2018,6,27]],"date-time":"2018-06-27T20:09:22Z","timestamp":1530130162000},"page":"316-320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma"],"prefix":"10.1016","volume":"117","author":[{"given":"Jian","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-0162","authenticated-orcid":false,"given":"Chun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7717-2244","authenticated-orcid":false,"given":"Fengqiang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.wneu.2018.06.150_bib1","doi-asserted-by":"crossref","first-page":"e187","DOI":"10.1212\/WNL.0000000000002213","article-title":"Journal Club: Randomized phase III study of whole-brain radiotherapy for primary CNS lymphoma","volume":"85","author":"Alnahhas","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2018.06.150_bib2","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/jcmm.12252","article-title":"Combined treatment of rituximab, idarubicin, dexamethasone, cytarabine, methotrexate with radiotherapy for primary central nervous system lymphoma","volume":"18","author":"Zhao","year":"2014","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.wneu.2018.06.150_bib3","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1517\/14656566.2015.1088828","article-title":"Present and future treatment options for primary CNS lymphoma","volume":"16","author":"Citterio","year":"2015","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.wneu.2018.06.150_bib4","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jocn.2012.04.001","article-title":"A\u00a0single centre study of the treatment of relapsed primary central nervous system lymphoma (PCNSL) with single agent temozolomide","volume":"19","author":"Wong","year":"2012","journal-title":"J\u00a0Clin Neurosci"},{"key":"10.1016\/j.wneu.2018.06.150_bib5","doi-asserted-by":"crossref","first-page":"534","DOI":"10.3324\/haematol.2014.108472","article-title":"Successful change of treatment strategy in elderly patients with primary central nervous system lymphoma by de-escalating induction and introducing temozolomide maintenance: results from a phase II study by the Nordic Lymphoma Group","volume":"100","author":"Pulczynski","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.wneu.2018.06.150_bib6","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1093\/annonc\/mdv076","article-title":"First-line treatment and outcome of elderly patients with primary central nervous system lymphoma (PCNSL): a systematic review and individual patient data meta-analysis","volume":"26","author":"Kasenda","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib7","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11060-011-0721-3","article-title":"O6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment","volume":"107","author":"Adachi","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib8","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.58.10.1573","article-title":"First-line therapy with temozolomide induces regression of primary CNS lymphoma","volume":"58","author":"Herrlinger","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.wneu.2018.06.150_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s11060-009-0032-0","article-title":"Primary CNS lymphoma in the elderly: temozolomide therapy and MGMT status","volume":"97","author":"Kurzwelly","year":"2010","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib10","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/s11060-011-0652-z","article-title":"Salvage treatment with temozolomide in refractory or relapsed primary central nervous system lymphoma and assessment of the MGMT status","volume":"106","author":"Makino","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib11","first-page":"247","article-title":"Relapsed or refractory primary central nervous system lymphoma radiosurgery: report of the International Gamma Knife Research Foundation","volume":"4","author":"Shin","year":"2017","journal-title":"J\u00a0Radiosurg SBRT"},{"key":"10.1016\/j.wneu.2018.06.150_bib12","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/neuonc\/not126","article-title":"Stereotactic iodine-125 brachytherapy for the treatment of WHO grades II and III gliomas located in the central sulcus region","volume":"15","author":"Ruge","year":"2013","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib13","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/sj.bjc.6603660","article-title":"Temozolomide as salvage treatment in primary brain lymphomas","volume":"96","author":"Reni","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.wneu.2018.06.150_bib14","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s11060-013-1162-y","article-title":"O6-methylguanine-DNA methyltransferase (MGMT) immunohistochemistry as a predictor of resistance to temozolomide in primary CNS lymphoma","volume":"114","author":"Jiang","year":"2013","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib15","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11060-012-0889-1","article-title":"Stereotactic iodine-125 brachytherapy for treatment of inoperable focal brainstem gliomas of WHO grades I and II: feasibility and long-term outcome","volume":"109","author":"Ruge","year":"2012","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.wneu.2018.06.150_bib16","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2739\/kurumemedj.48.281","article-title":"Intraarterial corticosteroid infusion following radiotherapy for primary central nervous system lymphoma: feasibility and preliminary result","volume":"48","author":"Hayabuchi","year":"2001","journal-title":"Kurume Med J"}],"container-title":["World Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018313664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878875018313664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T08:20:14Z","timestamp":1761812414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878875018313664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":16,"alternative-id":["S1878875018313664"],"URL":"https:\/\/doi.org\/10.1016\/j.wneu.2018.06.150","relation":{},"ISSN":["1878-8750"],"issn-type":[{"type":"print","value":"1878-8750"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic Brachytherapy with Iodine-125 Seeds Plus Temozolomide Induced Complete and Durable Remission in a Patient with Recurrent Primary Central Nervous System Lymphoma","name":"articletitle","label":"Article Title"},{"value":"World Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.wneu.2018.06.150","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}